Skip to main content

Table 1 Characteristic of the study population with sarcoidosis

From: Role of fibrocytes and endothelial progenitor cells among low-differentiated CD34+ cells in the progression of lung sarcoidosis

 

Patients

Sex: F/M (n)

15/11

Age (mean ± SD years)

45.2 ± 12.2

Women (mean ± SD years)

42.6 ± 11.8

Men (mean ± SD years)

46.7 ± 12.9

DLCO (%) (mean ± SD)

87.5 ± 17.1

 - >  80% (n, mean ± SD)

- 15, 96.8 ± 6.3

 - <  80% (n, mean ± SD)

- 11, 64.2 ± 11.7

Clinical symptoms (%)

 - Cough

15.8%

 - Dyspnoea

26.3%

 - Lymphadenopathy

100.0%

 - Pulmonary fibrosis

9.3%

Stage of disease (n,%)

 I

7 (26.9%)

 II

17 (65.4%)

 III

2 (7.7%)

  1. Abbreviations: F female, M male, DLCO Diffusing capacity for carbon monoxide